HighMark Wealth Management’s PhenomeX CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-550
Closed -$549 – 610
2023
Q3
$549 Hold
550
– – ﹤0.01% 529
2023
Q2
$270 Hold
550
– – ﹤0.01% 536
2023
Q1
$638 Hold
550
– – ﹤0.01% 559
2022
Q4
$1.47K Hold
550
– – ﹤0.01% 453
2022
Q3
$2K Hold
550
– – ﹤0.01% 452
2022
Q2
$3K Hold
550
– – ﹤0.01% 418
2022
Q1
$4K Buy
+550
New +$4.55K ﹤0.01% 402

HighMark Wealth Management's CELL Position: Q4 2023 in Review

HighMark Wealth Management sold out of PhenomeX (CELL) in Q4 2023, closing a stake of 550 shares — an estimated $549 sold.

HighMark Wealth Management first reported a position in CELL in Q1 2022 and held it in 7 quarters. The position peaked at $4K in Q1 2022. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

  • HighMark Wealth Management reported no remaining PhenomeX position as of Q4 2023 after selling out during the quarter.
  • HighMark Wealth Management sold 550 PhenomeX shares in Q4 2023, an estimated $549.
  • HighMark Wealth Management first reported a position in PhenomeX in Q1 2022 and held it in 7 quarters.
  • HighMark Wealth Management's PhenomeX position peaked at $4K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held PhenomeX as of Q4 2023.

Based on HighMark Wealth Management's 13F filing for Q4 2023, filed 23 Jan 2024.